The Latin America, Middle East and Africa HIV Injection Market would witness market growth of 19.8% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA HIV Injection Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $52.8 Million by 2029. The Argentina market is showcasing a CAGR of 20.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 19.4% during (2023 - 2030).
Studies have shown that adherence to oral antiretroviral therapy can be challenging for some patients, leading to suboptimal treatment outcomes and an increased risk of developing drug resistance. Injectable treatments, by contrast, are administered by healthcare providers, which can help ensure that patients receive their medications as prescribed. This can be especially important for patients who may struggle with adherence or who may be at risk of forgetting to take their medications.
The development of new antiretroviral drugs and treatment regimens has expanded the options available for injectable treatments, providing patients with more effective and convenient treatment options. One of the key advancements in HIV treatment has been the development of long-acting injectable therapies. These medications are administered less frequently than traditional oral medications, ranging from once a week to once every few months, depending on the specific drug.
Sub-Saharan Africa is classified as the region with the highest prevalence rates of HIV/AIDS on a global scale, with certain countries within the area bearing the brunt of this burden. For example, countries in southern Africa, such as South Africa, Swaziland, and Lesotho, have among the highest prevalence rates in the world. Hence, all of these factors will significantly support the expansion of the market in this region.
Free Valuable Insights: The Worldwide HIV Injection Market is Projected to reach USD 2.8 Billion by 2030, at a CAGR of 17.6%
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Gilead Sciences, Inc.
- ImmunityBio, Inc.
- F.Hoffmann-La Roche Ltd.
- Theratechnologies Inc.
- Viriom, Inc.
- AbbVie, Inc.
- Brii Biosciences Limited
- Shionogi & Co., Ltd.
- Boehringer Ingelheim International GmbH
LAMEA HIV Injection Market Report Segmentation
By Distribution Channel
- Hospital Pharmacy
- Drugs Stores & Retail Pharmacies
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA HIV Injection Market, by Distribution Channel
1.4.2 LAMEA HIV Injection Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. LAMEA HIV Injection Market by Distribution Channel
4.1 LAMEA Hospital Pharmacy Market by Country
4.2 LAMEA Drugs Stores & Retail Pharmacies Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA HIV Injection Market by Country
5.1 Brazil HIV Injection Market
5.1.1 Brazil HIV Injection Market by Distribution Channel
5.2 Argentina HIV Injection Market
5.2.1 Argentina HIV Injection Market by Distribution Channel
5.3 UAE HIV Injection Market
5.3.1 UAE HIV Injection Market by Distribution Channel
5.4 Saudi Arabia HIV Injection Market
5.4.1 Saudi Arabia HIV Injection Market by Distribution Channel
5.5 South Africa HIV Injection Market
5.5.1 South Africa HIV Injection Market by Distribution Channel
5.6 Nigeria HIV Injection Market
5.6.1 Nigeria HIV Injection Market by Distribution Channel
5.7 Rest of LAMEA HIV Injection Market
5.7.1 Rest of LAMEA HIV Injection Market by Distribution Channel
Chapter 6. Company Profiles
6.1 GlaxoSmithKline PLC (GSK)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.1 Gilead Sciences, Inc.
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expenses
6.1.4 SWOT Analysis
6.2 ImmunityBio, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 SWOT Analysis
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 SWOT Analysis
6.4 Theratechnologies Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Research & Development Expenses
6.4.4 SWOT Analysis
6.5 Viriom, Inc.
6.5.1 Company Overview
6.5.2 SWOT Analysis
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 SWOT Analysis
6.7 Brii Biosciences Limited
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.7.4 SWOT Analysis
6.8 Shionogi & Co., Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Expenses
6.8.4 SWOT Analysis
6.9 Boehringer Ingelheim International GmbH
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional & Segmental Analysis
6.9.4 Research & Development Expenses
6.9.5 SWOT Analysis
TABLE 1 LAMEA HIV Injection Market, 2019 - 2022, USD Million
TABLE 2 LAMEA HIV Injection Market, 2023 - 2030, USD Million
TABLE 3 LAMEA HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 4 LAMEA HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 5 LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA HIV Injection Market by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA HIV Injection Market by Country, 2023 - 2030, USD Million
TABLE 13 Brazil HIV Injection Market, 2019 - 2022, USD Million
TABLE 14 Brazil HIV Injection Market, 2023 - 2030, USD Million
TABLE 15 Brazil HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 16 Brazil HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 17 Argentina HIV Injection Market, 2019 - 2022, USD Million
TABLE 18 Argentina HIV Injection Market, 2023 - 2030, USD Million
TABLE 19 Argentina HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 20 Argentina HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 21 UAE HIV Injection Market, 2019 - 2022, USD Million
TABLE 22 UAE HIV Injection Market, 2023 - 2030, USD Million
TABLE 23 UAE HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 24 UAE HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 25 Saudi Arabia HIV Injection Market, 2019 - 2022, USD Million
TABLE 26 Saudi Arabia HIV Injection Market, 2023 - 2030, USD Million
TABLE 27 Saudi Arabia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 28 Saudi Arabia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 29 South Africa HIV Injection Market, 2019 - 2022, USD Million
TABLE 30 South Africa HIV Injection Market, 2023 - 2030, USD Million
TABLE 31 South Africa HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 32 South Africa HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 33 Nigeria HIV Injection Market, 2019 - 2022, USD Million
TABLE 34 Nigeria HIV Injection Market, 2023 - 2030, USD Million
TABLE 35 Nigeria HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 36 Nigeria HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 37 Rest of LAMEA HIV Injection Market, 2019 - 2022, USD Million
TABLE 38 Rest of LAMEA HIV Injection Market, 2023 - 2030, USD Million
TABLE 39 Rest of LAMEA HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 Rest of LAMEA HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 41 Key Information – GlaxoSmithKline PLC
TABLE 42 Key Information – Gilead Sciences, Inc.
TABLE 43 Key Information – ImmunityBio, Inc.
TABLE 44 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 45 Key Information – Theratechnologies Inc.
TABLE 46 Key Information – Viriom, Inc.
TABLE 47 Key information – AbbVie, Inc.
TABLE 48 Key Information – Brii Biosciences Limited
TABLE 49 Key Information – Shionogi & Co., Ltd.
TABLE 50 Key Information – Boehringer Ingelheim International GmbH
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA HIV Injection Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting HIV Injection Market
FIG 4 Porter’s Five Forces Analysis - HIV Injection Market
FIG 5 LAMEA HIV Injection Market share by Distribution Channel, 2022
FIG 6 LAMEA HIV Injection Market share by Distribution Channel, 2030
FIG 7 LAMEA HIV Injection Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 LAMEA HIV Injection Market share by Country, 2022
FIG 9 LAMEA HIV Injection Market share by Country, 2030
FIG 10 LAMEA HIV Injection Market by Country, 2019 - 2030, USD Million
FIG 11 SWOT Analysis: GlaxoSmithKline PLC
FIG 12 SWOT Analysis: Gilead Sciences, Inc.
FIG 13 SWOT Analysis: ImmunityBio, Inc.
FIG 14 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 15 SWOT Analysis: Theratechnologies Inc.
FIG 16 SWOT Analysis: Viriom, Inc.
FIG 17 Swot Analysis: AbbVie, Inc.
FIG 18 SWOT Analysis: Brii Biosciences Limited
FIG 19 SWOT Analysis: Shionogi & Co., Ltd.
FIG 20 SWOT Analysis: Boehringer Ingelheim International GmbH